In Europe, the incidence of multiple myeloma (MM) is 4.5 to 6.0 per 100,000 per year, with a mortality of 4.1 per 100,000 per year.[8] The median age at diagnosis is 72 years in Europe.[8]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer